Technical Specifications Compounds Included: GHK-Cu, BPC-157, TB-500 Total Peptide Content: 70 mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) Format: Lyophilized peptide blend Purity: 9899% (COA included) Appearance: Blue-tinted and white lyophilized peptide mixture Category: Research peptide reagent Intended Use Approved for: Laboratory experimentation In-vitro biochemical assays Multi-pathway mechanistic studies Preclinical, non-human research modeling Advanced peptide interaction analysis Academic or institutional research Not approved for: Human or veterinary consumption Injection, ingestion, inhalation, or topical application Cosmetic, dermatological, or therapeutic purposes Any clinical or medical application This product is not approved by FDA, Health Canada, or similar regulatory bodies for human use
The pharmacokinetic groundwork came from a Phase 1b trial studying cagrilintide alongside semaglutide 2.4 mg
Your body uses B12 as a cofactor in DNA synthesis, fatty acid metabolism, and homocysteine regulation
Reduction of Hyperpigmentation Whether caused by sun exposure, hormonal changes, or acne scars, hyperpigmentation can make the skin look patchy and dull
A 2025 systematic review in the HSS Journal identified 36 studies from 1993 to 2024, with consistent findings across multiple animal models and injury types
GH-axis stimulation can impair insulin sensitivity
